Theranostics is booming. Evidence, regulation, and operations aren't keeping pace.

A practical framework for nuclear medicine departments navigating radiopharmaceutical therapy — from imaging eligibility and dosimetry standardization to alpha-emitter regulatory risk and operational readiness.